Billiontoone (NASDAQ:BLLN) CEO Sells $1,005,293.12 in Stock

Billiontoone, Inc. (NASDAQ:BLLN) CEO Oguzhan Atay sold 8,333 shares of the firm’s stock in a transaction on Monday, September 28th. The shares were sold at an average price of $120.64, for a total value of $1,005,293.12. Following the sale, the chief executive officer directly owned 8,333 shares of the company’s stock, valued at $1,005,293.12. This represents a 50.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oguzhan Atay also recently made the following trade(s):

• On Monday, September 28th, Oguzhan Atay sold 2,666 shares of Billiontoone stock. The stock was sold at an average price of $120.64, for a total transaction of $321,626.24.
• On Monday, September 14th, Oguzhan Atay sold 5,332 shares of Billiontoone stock. The stock was sold at an average price of $98.00, for a total transaction of $522,536.00.
• On Monday, September 14th, Oguzhan Atay sold 24,999 shares of Billiontoone stock. The shares were sold at an average price of $100.32, for a total transaction of $2,507,899.68.
• On Monday, August 3rd, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The shares were sold at an average price of $137.37, for a total transaction of $1,717,125.00.
• On Monday, August 3rd, Oguzhan Atay sold 32,500 shares of Billiontoone stock. The stock was sold at an average price of $136.95, for a total transaction of $4,450,875.00.
• On Thursday, July 9th, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The shares were sold at an average price of $126.10, for a total value of $1,576,250.00.
• On Monday, July 6th, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The stock was sold at an average price of $122.05, for a total value of $1,525,625.00.
• On Monday, July 6th, Oguzhan Atay sold 26,250 shares of Billiontoone stock. The stock was sold at an average price of $122.05, for a total value of $3,203,812.50.

Billiontoone Stock Performance

NASDAQ BLLN traded down $11.74 on Wednesday, reaching $106.44. The stock had a trading volume of 968,635 shares, compared to its average volume of 612,070. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. The firm has a fifty day moving average of $107.92 and a two-hundred day moving average of $99.53. Billiontoone, Inc. has a 1-year low of $61.96 and a 1-year high of $150.44. The company has a market cap of $5.02 billion and a P/E ratio of 168.83.

Billiontoone (NASDAQ:BLLN) last announced its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The company had revenue of $109.45 million during the quarter. On average, equities research analysts anticipate that Billiontoone, Inc. will post 0.83 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Weiss Ratings restated a “sell (d+)” rating on shares of Billiontoone in a research note on Friday, September 18th. Wall Street Zen cut shares of Billiontoone from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Canaccord Genuity Group began coverage on shares of Billiontoone in a research report on Wednesday, September 2nd. They set a “buy” rating and a $120.00 price objective for the company. JPMorgan Chase & Co. cut their target price on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research report on Thursday, August 6th. Finally, BTIG Research lowered their price target on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a report on Thursday, August 6th. Seven research analysts have rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $125.88.

Hedge Funds Weigh In On Billiontoone

A number of hedge funds have recently modified their holdings of BLLN. Adams Street Partners LLC acquired a new stake in Billiontoone in the fourth quarter valued at $140,063,000. Wasatch Advisors LP grew its position in shares of Billiontoone by 40.2% in the 2nd quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock valued at $62,160,000 after buying an additional 148,446 shares during the last quarter. Emerald Advisers LLC grew its position in shares of Billiontoone by 26.8% in the 1st quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock valued at $18,911,000 after buying an additional 50,613 shares during the last quarter. Capital International Investors acquired a new stake in shares of Billiontoone in the fourth quarter valued at about $14,568,000. Finally, Emerald Mutual Fund Advisers Trust raised its position in shares of Billiontoone by 11.9% during the first quarter. Emerald Mutual Fund Advisers Trust now owns 132,206 shares of the company’s stock worth $10,436,000 after acquiring an additional 14,072 shares during the last quarter.

Billiontoone Company Profile

BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company’s platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.

BillionToOne’s primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.